180 related articles for article (PubMed ID: 27744117)
1. Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R).
Geller DS; Morris J; Revskaya E; Kahn M; Zhang W; Piperdi S; Park A; Koirala P; Guzik H; Hall C; Hoang B; Yang R; Roth M; Gill J; Gorlick R; Dadachova E
Nucl Med Biol; 2016 Dec; 43(12):812-817. PubMed ID: 27744117
[TBL] [Abstract][Full Text] [Related]
2. Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors.
Karkare S; Allen KJH; Jiao R; Malo ME; Dawicki W; Helal M; Godson DL; Dickinson R; MacDonald-Dickinson V; Yang R; Hoang B; Gorlick R; Geller DS; Dadachova E
Sci Rep; 2019 Aug; 9(1):11476. PubMed ID: 31391495
[TBL] [Abstract][Full Text] [Related]
3. Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma.
Broqueza J; Prabaharan CB; Andrahennadi S; Allen KJH; Dickinson R; MacDonald-Dickinson V; Dadachova E; Uppalapati M
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34064450
[TBL] [Abstract][Full Text] [Related]
4. 166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabel.
Thompson S; Ballard B; Jiang Z; Revskaya E; Sisay N; Miller WH; Cutler CS; Dadachova E; Francesconi LC
Nucl Med Biol; 2014 Mar; 41(3):276-81. PubMed ID: 24533987
[TBL] [Abstract][Full Text] [Related]
5. Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach.
Boisclair C; Dickinson R; Giri S; Dadachova E; MacDonald-Dickinson V
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768202
[TBL] [Abstract][Full Text] [Related]
6. Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).
Prabaharan CB; Giri S; Allen KJH; Bato KEM; Mercado TR; Malo ME; Carvalho JLC; Dadachova E; Uppalapati M
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570809
[TBL] [Abstract][Full Text] [Related]
7. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
[TBL] [Abstract][Full Text] [Related]
8. B7-H3-targeted
Kasten BB; Arend RC; Katre AA; Kim H; Fan J; Ferrone S; Zinn KR; Buchsbaum DJ
Nucl Med Biol; 2017 Apr; 47():23-30. PubMed ID: 28104527
[TBL] [Abstract][Full Text] [Related]
9. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
Buchsbaum DJ; Wahl RL; Normolle DP; Kaminski MS
Cancer Res; 1992 Dec; 52(23):6476-81. PubMed ID: 1423295
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models.
Broqueza J; Prabaharan CB; Allen KJH; Jiao R; Fisher DR; Dickinson R; MacDonald-Dickinson V; Uppalapati M; Dadachova E
Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056067
[TBL] [Abstract][Full Text] [Related]
11.
Kasten BB; Gangrade A; Kim H; Fan J; Ferrone S; Ferrone CR; Zinn KR; Buchsbaum DJ
Nucl Med Biol; 2018 Mar; 58():67-73. PubMed ID: 29413459
[TBL] [Abstract][Full Text] [Related]
12. The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of (188)re-labeled anti-E6 C1P5 antibody in cervical cancer in mice.
Phaeton R; Wang XG; Einstein MH; Goldberg GL; Casadevall A; Dadachova E
Cancer; 2010 Feb; 116(4 Suppl):1067-74. PubMed ID: 20127955
[TBL] [Abstract][Full Text] [Related]
13. Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy.
Jandl T; Revskaya E; Jiang Z; Harris M; Dorokhova O; Tsukrov D; Casadevall A; Dadachova E
Nucl Med Biol; 2013 Feb; 40(2):177-81. PubMed ID: 23146306
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer.
Deshayes E; Ladjohounlou R; Le Fur P; Pichard A; Lozza C; Boudousq V; Sevestre S; Jarlier M; Kashani R; Koch J; Sosabowski J; Foster J; Chouin N; Bruchertseifer F; Morgenstern A; Kotzki PO; Navarro-Teulon I; Pouget JP
J Nucl Med; 2018 Aug; 59(8):1234-1242. PubMed ID: 29674421
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5.
Tsai SW; Sun Y; Williams LE; Raubitschek AA; Wu AM; Shively JE
Bioconjug Chem; 2000; 11(3):327-34. PubMed ID: 10821648
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia.
De Decker M; Bacher K; Thierens H; Slegers G; Dierckx RA; De Vos F
Nucl Med Biol; 2008 Jul; 35(5):599-604. PubMed ID: 18589304
[TBL] [Abstract][Full Text] [Related]
18. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma.
Westrøm S; Bønsdorff TB; Abbas N; Bruland ØS; Jonasdottir TJ; Mælandsmo GM; Larsen RH
PLoS One; 2016; 11(10):e0165382. PubMed ID: 27776176
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [
Chan C; Fonge H; Lam K; Reilly RM
Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
